The company is focused on reaching a larger U.S. population of individuals living with a spinal cord injury and anticipate increased demand for Ekso Indego Personal in the second half of the year and longer term. They will continue to execute upon their scalable commercial strategy to drive growth while bringing transformational benefits to patients across the continuum of care.